Skip to content

Clinical trials

Obesity trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Country / region: Austria Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20061
20072
20092
20103
20113
20122
20132
20154
20163
20173
20184
20194
20202
20212
20222
20238
20248
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting14
Terminated8
Unknown status8
Active, not recruiting7
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Graz10
Medical University of Vienna10
Novo Nordisk A/S9
Eli Lilly and Company5
Amgen3
AstraZeneca2
Green Beat2
Novartis Pharmaceuticals2
Sanofi2
Alexandra Kautzky-Willer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity69
Overweight22
Diabetes Mellitus, Type 214
Diabetes Mellitus9
Cardiovascular Diseases5
Insulin Resistance5
Prediabetic State4
Weight Loss4
Atherosclerosis3
Fatty Liver3

Trials

Showing 1 to 25 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.